California Life Sciences Political Action Committee

View

Source Type	Amount	Percentage
Other	$2.26M	94.1%
Committee	$80.3K	3.3%
Individual	$62K	2.6%
Total	$2.41M	100%

Itemized Group by Donor

Donor	Total Amount	% of Total
Medimmune Other	~$X,XXX	0.1%
Eli Lilly and Company Other	~$X,XXX	0.1%
Woodruff-Sawyer & Company Other	~$X,XXX	0.1%
Invitrogrn Corporation Other	~$X,XXX	0.1%
Medlmmune Affairs, Inc. Other	~$X,XXX	0.1%
Abbvie Other	~$X,XXX	0.1%
Billiontoone, Inc. Other	~$X,XXX	0.1%
Revolution Medicines, Inc. Other	~$X,XXX	0.1%
Irhythm Technologies, Inc. Other	~$X,XXX	0.1%
Greenwich Biosciences Other	~$X,XXX	0.1%
Eisai, Inc. Other	~$X,XXX	0.1%
Novartis Corporation Other	~$X,XXX	0.1%
Personalis, Inc. Other	~$X,XXX	0.1%
Sila Nanotechnologies, Inc. Other	~$X,XXX	0.1%
Cue Health Inc. Other	~$X,XXX	0.1%
Alphatec Spine, Inc. Other	~$X,XXX	0.1%
Revance Therapeutics, Inc. Other	~$X,XXX	0.1%
Mark W. Ginestro Consultant at Ey	~$X,XXX	0.1%
Peter Claude Partner at Pwc, Llp	~$X,XXX	0.1%
Arnold & Porter Llp Other	~$X,XXX	0.1%
Ascendis Pharma a/S Other	~$X,XXX	0.1%
Assembly Biosciences Other	~$X,XXX	0.1%
Protagonist Therapeutics Inc. Other	~$X,XXX	0.1%
Zimmer Other	~$X,XXX	0.1%
Springer Nature Limited (Springer Sbm) Other	~$X,XXX	0.1%

Page 5 of 36